Drugs / Neurotropin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03897257 | Mar → Oct 2019 | tinea pedis | Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT07320950 | Apr 2022 → Aug 2025 | colorectal cancer | Sun Yat-sen University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00366535 Comparator | Aug 2006 → Dec 2015 | fibromyalgia | National Institute of Nursing Research (NINR) | Completed | No outcome recorded |
| Phase 2 | NCT00006289 Comparator | Sep 2000 → Jun 2012 | complex regional pain syndrome type 1, complex regional pain syndrome type 2 | National Institute of Nursing Research (NINR) | Terminated | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02168010 Comparator | Oct 2013 → Jul 2014 | — | VanWorld Pharmaceutical (Rugao) Company Limited | Completed | No outcome recorded |
| Phase 3 | NCT02633618 Comparator | Aug → Dec 2005 | neuropathy, painful | VanWorld Pharmaceutical (Rugao) Company Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neurotropin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07320950 ↗ |
| Known as | Drug B | “Drug B is a keratolytic agent.” NCT03897257 ↗ |
| Route | Oral | “receive neurotropin or placebo tablets” NCT00006289 ↗ |